Adaptive and mutational resistance: Role of porins and efflux pumps in drug resistance

Clinical Microbiology Reviews

Volumn 25, Issue 4, 2012, Pages 661-681

  Fernández, Lucía ^a   Hancock, Robert E W ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ABC TRANSPORTER; BETA LACTAM ANTIBIOTIC; CARBAPENEM DERIVATIVE; CARBENICILLIN; CEPHALOSPORIN DERIVATIVE; CHLORAMPHENICOL; CIPROFLOXACIN; DICLOFENAC; ERYTHROMYCIN; FUSIDATE SODIUM; NOVOBIOCIN; OUTER MEMBRANE PROTEIN A; OUTER MEMBRANE PROTEIN C; OUTER MEMBRANE PROTEIN D; OUTER MEMBRANE PROTEIN F; OUTER MEMBRANE PROTEIN U; PORIN; QUINOLINE DERIVED ANTIINFECTIVE AGENT; RIFAMPICIN; SIDEROPHORE; UNCLASSIFIED DRUG;

ACINETOBACTER BAUMANNII; ADAPTATION; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ANTIBIOTIC THERAPY; ARTICLE; BACTERIAL GROWTH; BACTERIAL OUTER MEMBRANE; BACTERIAL STRAIN; BACTERIAL VIRULENCE; BIOFILM; EFFLUX PUMP; ESCHERICHIA COLI; GENE CONTROL; GENE MUTATION; HUMAN; MEMBRANE PERMEABILITY; MEMBRANE TRANSPORT; MINIMUM INHIBITORY CONCENTRATION; MULTIDRUG RESISTANCE; NONHUMAN; PHENOTYPIC VARIATION; PROMOTER REGION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN STRUCTURE; PSEUDOMONAS AERUGINOSA;

ADAPTATION, PHYSIOLOGICAL; ANIMALS; BACTERIA; BACTERIAL INFECTIONS; BACTERIAL PHYSIOLOGICAL PHENOMENA; BACTERIAL PROTEINS; DRUG RESISTANCE, BACTERIAL; HUMANS; MEMBRANE TRANSPORT PROTEINS; MICE; MUTATION; PORINS;

EID: 84867184096     PISSN: 08938512     EISSN: 10986618     Source Type: Journal    
DOI: 10.1128/CMR.00043-12     Document Type: Article

References (272)

1. Achouak W, Heulin T, Pagès JM. 2001. Multiple facets of bacterial porins. FEMS Microbiol. Lett. 199:1-7.
2. Aires JR, Kohler T, Nikaido H, Plesiat P. 1999. Involvement of an active efflux system in the natural resistance of Pseudomonas aeruginosa to aminoglycosides. Antimicrob. Agents Chemother. 43:2624-2628.
3. Akiba M, Lin J, Barton YW, Zhang Q. 2006. Interaction of CmeABC and CmeDEF in conferring antimicrobial resistance and maintaining cell viability in Campylobacter jejuni. J. Antimicrob. Chemother. 57:52-60.
4. Alakomi HL, et al. 2000. Lactic acid permeabilizes gram-negative bacteria by disrupting the outer membrane. Appl. Environ. Microbiol. 66: 2001-2005.
5. Alekshun MN, Levy SB. 1999. Alteration of the repressor activity of MarR, the negative regulator of the Escherichia coli marRAB locus, by multiple chemicals in vitro. J. Bacteriol. 181:4669-4672.
6. Al-Hamad A, Burnie J, Upton M. 2011. Enhancement of antibiotic susceptibility of Stenotrophomonas maltophilia using a polyclonal antibody developed against an ABC multidrug efflux pump. Can. J. Microbiol. 57:820-828.
7. Alonso A, Martinez JL. 2000. Cloning and characterization of SmeDEF, a novel multidrug efflux pump from Stenotrophomonas maltophilia. Antimicrob. Agents Chemother. 44:3079-3086.
8. Aono R, Tsukagoshi N, Yamamoto M. 1998. Involvement of outer membrane protein TolC, a possible member of the mar-sox regulon, in maintenance and improvement of organic solvent tolerance of Escherichia coli K-12. J. Bacteriol. 180:938-944.
9. Armand-Lefèvre L, et al. 2003. Imipenem resistance in Salmonella enterica serovar Wien related to porin loss and CMY-4 beta-lactamase production. Antimicrob. Agents Chemother. 47:1165-1168.
10. Ayres HM, Payne DN, Furr JR, Russell AD. 1998. Effect of permeabilizing agents on antibacterial activity against a simple Pseudomonas aeruginosa biofilm. Lett. Appl. Microbiol. 27:79-82.
11. Ball PR, Shales SW, Chopra I. 1980. Plasmid-mediated tetracycline resistance in Escherichia coli involves increased efflux of the antibiotic. Biochem. Biophys. Res. Commun. 93:74-81.
12. Ballestero S, et al. 1996. Carbapenem resistance in Pseudomonas aeruginosa from cystic fibrosis patients. J. Antimicrob. Chemother. 38:39-45.
13. Baquero F. 2001. Low-level antibacterial resistance: a gateway to clinical resistance. Drug Resist. Updat. 4:93-105.
14. Baranova N, Nikaido H. 2002. The BaeSR two-component regulatory system activates transcription of the yegMNOB (mdtABCD) transporter gene cluster in Escherichia coli and increases its resistance to novobiocin and deoxycholate. J. Bacteriol. 184:4168-4176.
15. Barbosa TM, Levy SB. 2000. Differential expression of over 60 chromosomal genes in Escherichia coli by constitutive expression of MarA. J. Bacteriol. 182:3467-3474.
16. Barclay ML, et al. 1996. Adaptive resistance to tobramycin in Pseudomonas aeruginosa lung infection in cystic fibrosis. J. Antimicrob. Chemother. 37:1155-1164.
17. Bean DC, Wareham DW. 2009. Paradoxical effect of 1-(1-naphthylmethyl)-piperazine on resistance to tetracyclines in multidrug-resistant Acinetobacter baumannii. J. Antimicrob. Chemother. 63:349-352.
18. Beceiro A, et al. 2011. False extended-spectrum beta-lactamase phenotype in clinical isolates of Escherichia coli associated with increased expression of OXA-1 or TEM-1 penicillinases and loss of porins. J. Antimicrob. Chemother. 66:2006-2010.
19. Begic S, Worobec EA. 2006. Regulation of Serratia marcescens ompF and ompC porin genes in response to osmotic stress, salicylate, temperature and pH. Microbiology 152:485-491.
20. Begic S, Worobec EA. 2008. Characterization of the Serratia marcescens SdeCDE multidrug efflux pump studied via gene knockout mutagenesis. Can. J. Microbiol. 54:411-416.
21. Begum A, et al. 2005. Gene cloning and characterization of four MATE family multidrug efflux pumps from Vibrio cholerae non-O1. Microbiol. Immunol. 49:949-957.
22. Bina JE, Provenzano D, Wang C, Bina XR, Mekalanos JJ. 2006. Characterization of the Vibrio cholerae vexAB and vexCD efflux systems. Arch. Microbiol. 186:171-181.
23. Bore E, et al. 2007. Adapted tolerance to benzalkonium chloride in Escherichia coli K-12 studied by transcriptome and proteome analyses. Microbiology 153:935-946.
24. Boutoille D, et al. 2004. Detection of an IS21 insertion sequence in the mexR gene of Pseudomonas aeruginosa increasing beta-lactam resistance. FEMS Microbiol. Lett. 230:143-146.
25. Briers Y, Walmagh M, Lavigne R. 2011. Use of bacteriophage endolysin EL188 and outer membrane permeabilizers against Pseudomonas aeruginosa. J. Appl. Microbiol. 110:778-785.
26. Brooun A, Tomashek JJ, Lewis K. 1999. Purification and ligand binding of EmrR, a regulator of a multidrug transporter. J. Bacteriol. 181:5131-5133.
27. Butaye P, Cloeckaert A, Schwarz S. 2003. Mobile genes coding for efflux-mediated antimicrobial resistance in Gram-positive and Gramnegative bacteria. Int. J. Antimicrob. Agents 22:205-210.
28. Cao L, Srikumar R, Poole K. 2004. MexAB-OprM hyperexpression in NalC-type multidrug-resistant Pseudomonas aeruginosa: identification and characterization of the nalC gene encoding a repressor of PA3720-PA3719. Mol. Microbiol. 53:1423-1436.
29. Castillo-Keller M, Vuong P, Misra R. 2006. Novel mechanism of Escherichia coli porin regulation. J. Bacteriol. 188:576-586.
30. Cattoir V, Poirel L, Nordmann P. 2008. Plasmid-mediated quinolone resistance pump QepA2 in an Escherichia coli isolate from France. Antimicrob. Agents Chemother. 52:3801-3804.
31. Chan YY, Chua KL. 2005. The Burkholderia pseudomallei BpeAB-OprB efflux pump: expression and impact on quorum sensing and virulence. J. Bacteriol. 187:4707-4719.
32. Chan YY, Tan TM, Ong YM, Chua KL. 2004. BpeAB-OprB, a multidrug efflux pump in Burkholderia pseudomallei. Antimicrob. Agents Chemother. 48:1128-1135.
33. Chancey ST, Zhou X, Zähner D, Stephens DS. 2011. Induction of efflux-mediated macrolide resistance in Streptococcus pneumoniae. Antimicrob. Agents Chemother. 55:3413-3422.
34. Chen J, Kuroda T, Huda MN, Mizushima T, Tsuchiya T. 2003. An RND-type multidrug efflux pump SdeXY from Serratia marcescens. J. Antimicrob. Chemother. 52:176-179.
35. Chen FJ, Lauderdale TL, Ho M, Lo HJ. 2003. The roles of mutations in gyrA, parC, and ompK35 in fluoroquinolone resistance in Klebsiella pneumoniae. Microb. Drug Resist. 9:265-271.
36. Chen LR, Zhou HW, Cai JC, Zhang R, Chen GX. 2009. Combination of IMP-4 metallo-beta-lactamase production and porin deficiency causes carbapenem resistance in a Klebsiella oxytoca clinical isolate. Diagn. Microbiol. Infect. Dis. 65:163-167.
37. Chuanchuen R, et al. 2001. Cross-resistance between triclosan and antibiotics in Pseudomonas aeruginosa is mediated by multidrug efflux pumps: exposure of a susceptible mutant strain to triclosan selects nfxB mutants overexpressing MexCD-OprJ. Antimicrob. Agents Chemother. 45:428-432.
38. Chuanchuen R, Narasaki CT, Schweizer HP. 2002. The MexJK efflux pump of Pseudomonas aeruginosa requires OprM for antibiotic efflux but not for efflux of triclosan. J. Bacteriol. 184:5036-5044.
39. Clancy J, et al. 1996. Molecular cloning and functional analysis of a novel macrolide-resistance determinant, mefA, from Streptococcus pyogenes. Mol. Microbiol. 22:867-879.
40. Colmer JA, Fralick JA, Hamood AN. 1998. Isolation and characterization of a putative multidrug resistance pump from Vibrio cholerae. Mol. Microbiol. 27:63-72.
41. Cortez-Cordova J, Kumar A. 2011. Activity of the efflux pump inhibitor phenylalanine-arginine β-naphthylamide against the AdeFGH pump of Acinetobacter baumannii. Int. J. Antimicrob. Agents 37:420-424.
42. Coyne S, Rosenfeld N, Lambert T, Courvalin P, Périchon B. 2010. Overexpression of resistance-nodulation-cell division pump AdeFGH confers multidrug resistance in Acinetobacter baumannii. Antimicrob. Agents Chemother. 54:4389-4393.
43. Crossman LC, et al. 2008. The complete genome, comparative and functional analysis of Stenotrophomonas maltophilia reveals an organism heavily shielded by drug resistance determinants. Genome Biol. 9:R74. doi:10.1186/gb-2008-9-4-r74.
44. Daigle DM, et al. 2007. Protein modulator of multidrug efflux gene expression in Pseudomonas aeruginosa. J. Bacteriol. 189:5441-5451.
45. Daikos GL, Lolans VT, Jackson GG. 1991. First-exposure adaptive resistance to aminoglycoside antibiotics in vivo with meaning for optimal clinical use. Antimicrob. Agents Chemother. 35:117-123.
46. Damier-Piolle L, Magnet S, Bremont S, Lambert T, Courvalin P. 2008. AdeIJK, a resistance-nodulation-cell division pump effluxing multiple antibiotics in Acinetobacter baumannii. Antimicrob. Agents Chemother. 52:557-562.
47. Danilchanka O, Mailaender C, Niederweis M. 2008. Identification of a novel multidrug efflux pump of Mycobacterium tuberculosis. Antimicrob. Agents Chemother. 52:2503-2511.
48. DÉ E, et al. 2001. A new mechanism of antibiotic resistance in Enterobacteriaceae induced by a structural modification of the major porin. Mol. Microbiol. 41:189-198.
49. De la Cruz MA, Calva E. 2010. The complexities of porin genetic regulation. J. Mol. Microbiol. Biotechnol. 18:24-36.
50. DeMarco CE, et al. 2007. Efflux-related resistance to norfloxacin, dyes, and biocides in bloodstream isolates of Staphylococcus aureus. Antimicrob. Agents Chemother. 51:3235-3239.
51. Deng X, et al. 2012. Expression of multidrug resistance efflux pump gene norA is iron responsive in Staphylococcus aureus. J. Bacteriol. 194: 1753-1762.
52. Diggle SP, Winzer K, Lazdunski A, Williams P, Cámara M. 2002. Advancing the quorum in Pseudomonas aeruginosa: MvaT and the regulation of N-acylhomoserine lactone production and virulence gene expression. J. Bacteriol. 184:2576-2586.
53. Doménech-Sánchez A, et al. 2003. Role of Klebsiella pneumonia OmpK35 porin in antimicrobial resistance. Antimicrob. Agents Chemother. 47:3332-3335.
54. Doumith M, Ellington MJ, Livermore DM, Woodford N. 2009. Molecular mechanisms disrupting porin expression in ertapenem-resistant Klebsiella and Enterobacter spp. clinical isolates from the UK. J. Antimicrob. Chemother. 63:659-667.
55. Dupont M, DÉ E, Chollet R, Chevalier J, Pagès JM. 2004. Enterobacter aerogenes OmpX, a cation-selective channel mar- and osmo-regulated. FEBS Lett. 569:27-30.
56. Dupont M, James CE, Chevalier J, Pagès JM. 2007. An early response to environmental stress involves regulation of OmpX and OmpF, two enterobacterial outer membrane pore-forming proteins. Antimicrob. Agents Chemother. 51:3190-3198.
57. El'Garch F, Jeannot K, Hocquet D, Llanes-Barakat Plesiat P. 2007. Cumulative effects of several nonenzymatic mechanisms on the resistance of Pseudomonas aeruginosa to aminoglycosides. Antimicrob. Agents Chemother. 51:1016-1021.
58. El Garch F, et al. 2010. Fluoroquinolones induce the expression of patA and patB, which encode ABC efflux pumps in Streptococcus pneumoniae. J. Antimicrob. Chemother. 65:2076-2082.
59. Fernández L, Breidenstein EBM, Hancock REW. 2011. Creeping baselines and adaptive resistance to antibiotics. Drug Resist. Updat. 14:1-21.
60. Fernandez L, Breidenstein EBM, Hancock REW. 2011. Importance of adaptive and stepwise changes in the rise and spread of antimicrobial resistance, p 43-72. In Keen PL, Montforts MHMM (ed), Antimicrobial resistance in the environment. John Wiley & Sons, Inc, Hoboken, NJ.
61. Fernández L, et al. 2010. Adaptive resistance to the "last hope" antibiotics polymyxin B and colistin in Pseudomonas aeruginosa is mediated by the novel two-component regulatory system ParR-ParS. Antimicrob. Agents Chemother. 54:3372-3382.
62. Floyd JL, Smith KP, Kumar SH, Floyd JT, Varela MF. 2010. LmrS is a multidrug efflux pump of the major facilitator superfamily from Staphylococcus aureus. Antimicrob. Agents Chemother. 54:5406-5412.
63. Fralick JA. 1996. Evidence that TolC is required for functioning of the Mar/AcrAB efflux pump of Escherichia coli. J. Bacteriol. 178:5803-5805.
64. Fraud S, Campigotto AJ, Chen Z, Poole K. 2008. MexCD-OprJ multidrug efflux system of Pseudomonas aeruginosa: involvement in chlorhexidine resistance and induction by membrane-damaging agents dependent upon the AlgU stress response sigma factor. Antimicrob. Agents Chemother. 52: 4478-4482.
65. Fraud S, Poole K. 2011. Oxidative stress induction of the MexXY multidrug efflux genes and promotion of aminoglycoside resistance development in Pseudomonas aeruginosa. Antimicrob. Agents Chemother. 55: 1068-1074.
66. Frempong-Manso E, Raygada JL, Demarco CE, Seo SM, Kaatz GW. 2009. Inability of a reserpine-based screen to identify strains overexpressing efflux pump genes in clinical isolates of Staphylococcus aureus. Int. J. Antimicrob. Agents 33:360-363.
67. Fukuda H, Hosaka M, Hirai K, Iyobe S. 1990. New norfloxacin resistance gene in Pseudomonas aeruginosa PAO. Antimicrob. Agents Chemother. 34:1757-1761.
68. Fukuda H, et al. 1995. nfxC-type quinolone resistance in a clinical isolate of Pseudomonas aeruginosa. Antimicrob. Agents Chemother. 39:790-792.
69. Garau G, Di Guilmi AM, Hall BG. 2005. Structure-based phylogeny of the metallo-lactamases. Antimicrob. Agents Chemother. 49:2778-2784.
70. Garrido MC, Herrero M, Kolter R, Moreno F. 1988. The export of the DNA replication inhibitor microcin B17 provides immunity for the host cell. EMBO J. 7:1853-1862.
71. Garvey MI, Piddock LJ. 2008. The efflux pump inhibitor reserpine selects multidrug-resistant Streptococcus pneumoniae strains that overexpress the ABC transporters PatA and PatB. Antimicrob. Agents Chemother. 52:1677-1685.
72. Giacometti A, et al. 2000. Comparative activities of polycationic peptides and clinically used antimicrobial agents against multidrug-resistant nosocomial isolates of Acinetobacter baumannii. J. Antimicrob. Chemother. 46:807-810.
73. Gill MJ, et al. 1998. Gonococcal resistance to beta-lactams and tetracycline involves mutation in loop 3 of the porin encoded at the penB locus. Antimicrob. Agents Chemother. 42:2799-2803.
74. Gillis RJ, et al. 2005. Molecular basis of azithromycin-resistant Pseudomonas aeruginosa biofilms. Antimicrob. Agents Chemother. 49:3858-3867.
75. Godreuil S, Galimand M, Gerbaud G, Jacquet C, Courvalin P. 2003. Efflux pump Lde is associated with fluoroquinolone resistance in Listeria monocytogenes. Antimicrob. Agents Chemother. 47:704-708.
76. Griffith JK, et al. 1992. Membrane transport proteins: implications of sequence comparisons. Curr. Opin. Cell Biol. 4:684-695.
77. Griffith DC, et al. 2006. Pharmacodynamics of levofloxacin against Pseudomonas aeruginosa with reduced susceptibility due to different efflux pumps: do elevated MICs always predict reduced in vivo efficacy? Antimicrob. Agents Chemother. 50:1628-1632.
78. Griffith D, Lomovskaya O, Lee V, Dudley M. 1999. Potentiation of levofloxacin by a broad-spectrum efflux pump inhibitor in mouse models of infection caused by Pseudomonas aeruginosa, abstr 1496. Abstr. 39th Intersci. Conf. Antimicrob. Agents Chemother., San Francisco, CA.
79. Gülmez D, et al. 2008. Carbapenem-resistant Escherichia coli and Klebsiella pneumoniae isolates from Turkey with OXA-48-like carbapenemases and outer membrane protein loss. Int. J. Antimicrob. Agents 31:523-526.
80. Hagman KE, et al. 1995. Resistance of Neisseria gonorrhoeae to antimicrobial hydrophobic agents is modulated by the mtrRCDE efflux system. Microbiology 141:611-622.
81. Hall BG, Barlow M. 2004. Evolution of the serine-lactamases: past, present and future. Drug Resist. Updat. 7:111-123.
82. Hall MN, Silhavy TJ. 1981. The ompB locus and the regulation of the major outer membrane porin proteins of Escherichia coli K12. J. Mol. Biol. 146:23-43.
83. Hancock REW. 1984. Alterations in outer membrane permeability. Annu. Rev. Microbiol. 38:237-264.
84. Harder KJ, Nikaido H, Matsuhashi M. 1981. Mutants of Escherichia coli that are resistant to certain beta-lactam compounds lack the ompF porin. Antimicrob. Agents Chemother. 20:549-552.
85. Hartog E, Menashe O, Kler E, Yaron S. 2010. Salicylate reduces the antimicrobial activity of ciprofloxacin against extracellular Salmonella enterica serovar Typhimurium, but not against Salmonella in macrophages. J. Antimicrob. Chemother. 65:888-896.
86. He GX, et al. 2011. EmmdR, a new member of the MATE family of multidrug transporters, extrudes quinolones from Enterobacter cloacae. Arch. Microbiol. 193:759-765.
87. Helander IM, Alakomi HL, Latva-Kala K, Koski P. 1997. Polyethyleneimine is an effective permeabilizer of gram-negative bacteria. Microbiology 143:3193-3199.
88. Henrichfreise B, Wiegand I, Luhmer-Becker I, Wiedemann B. 2007. Development of resistance in wild-type and hypermutable Pseudomonas aeruginosa strains exposed to clinical pharmacokinetic profiles of meropenem and ceftazidime simulated in vitro. Antimicrob. Agents Chemother. 51:3642-3649.
89. Hernández A, Ruiz FM, Romero A, Martínez JL. 2011. The binding of triclosan to SmeT, the repressor of the multidrug efflux pump SmeDEF, induces antibiotic resistance in Stenotrophomonas maltophilia. PLoS Pathog. 7:e1002103. doi:10.1371/journal.ppat.1002103.
90. Hernould M, Gagne S, Fournier M, Quentin C, Arpin C. 2008. Role of the AheABC efflux pump in Aeromonas hydrophila intrinsic multidrug resistance. Antimicrob. Agents Chemother. 52:1559-1563.
91. Higgins PG, Schneiders T, Hamprecht A, Seifert H. 2010. In vivo selection of a missense mutation in adeR and conversion of the novel blaOXA-164 gene into blaOXA-58 in carbapenem-resistant Acinetobacter baumannii isolates from a hospitalized patient. Antimicrob. Agents Chemother. 54:5021-5027.
92. Hirai K, Suzue S, Irikura T, Iyobe S, Mitsuhashi S. 1987. Mutations producing resistance to norfloxacin in Pseudomonas aeruginosa. Antimicrob. Agents Chemother. 31:582-586.
93. Hirakata Y, et al. 2002. Multidrug efflux systems play an important role in the invasiveness of Pseudomonas aeruginosa. J. Exp. Med. 196:109-118.
94. Hocquet D, et al. 2003. MexXY-OprM efflux pump is necessary for a adaptive resistance of Pseudomonas aeruginosa to aminoglycosides. Antimicrob. Agents Chemother. 47:1371-1375.
95. Hood MI, Jacobs AC, Sayood K, Dunman PM, Skaar EP. 2010. Acinetobacter baumannii increases tolerance to antibiotics in response to monovalent cations. Antimicrob. Agents Chemother. 54:1029-1041.
96. Huang H, Jeanteur D, Pattus F, Hancock REW. 1995. Membrane topology and site-specific mutagenesis of Pseudomonas aeruginosa porin OprD. Mol. Microbiol. 16:931-941.
97. Huang J, et al. 2004. Novel chromosomally encoded multidrug efflux transporter MdeA in Staphylococcus aureus. Antimicrob. Agents Chemother. 48:909-917.
98. Huda N, et al. 2003. Molecular cloning and characterization of an ABC multidrug efflux pump, VcaM, in non-O1 Vibrio cholerae. Antimicrob. Agents Chemother. 47:2413-2417.
99. Jaffe A, Chabbert YA, Semonin O. 1982. Role of porin proteins OmpF and OmpC in the permeation of beta-lactams. Antimicrob. Agents Chemother. 22:942-948.
100. Jeannot K, et al. 2008. Resistance and virulence of Pseudomonas aeruginosa clinical strains overproducing the MexCD-OprJ efflux pump. Antimicrob. Agents Chemother. 52:2455-2462.
101. Jetter M, Spaniol V, Troller R, Aebi C. 2010. Down-regulation of porin M35 in Moraxella catarrhalis by aminopenicillins and environmental factors and its potential contribution to the mechanism of resistance to aminopenicillins. J. Antimicrob. Chemother. 65:2089-2096.
102. Jin Y, Yang H, Qiao M, Jin S. 2011. MexT regulates the type III secretion system through MexS and PtrC in Pseudomonas aeruginosa. J. Bacteriol. 193:399-410.
103. Kadlec K, Kehrenberg C, Schwarz S. 2007. Efflux-mediated resistance to florfenicol and/or chloramphenicol in Bordetella bronchiseptica: identification of a novel chloramphenicol exporter. J. Antimicrob. Chemother. 59:191-196.
104. Kehrenberg C, Cloeckaert A, Klein G, Schwarz S. 2009. Decreased fluoroquinolone susceptibility in mutants of Salmonella serovars other than Typhimurium: detection of novel mutations involved in modulated expression of ramA and soxS. J. Antimicrob. Chemother. 64:1175-1180.
105. Kikuchi K, Bernard EM, Sadownik A, Regen SL, Armstrong D. 1997. Antimicrobial activities of squalamine mimics. Antimicrob. Agents Chemother. 41:1433-1438.
106. Kirby WMM. 1944. Extraction of a highly potent penicillin inactivator from penicillin-resistant staphylococci. Science 99:452-453.
107. Kobayashi N, Nishino K, Yamaguchi A. 2001. Novel macrolide-specific ABC-type efflux transporter in Escherichia coli. J. Bacteriol. 183:5639-5644.
108. Koebnik R, Locher KP, Van Gelder P. 2000. Structure and function of bacterial outer membrane proteins: barrels in a nutshell. Mol. Microbiol. 37:239-253.
109. Kohler T, Epp SF, Curty LK, Pechère JC. 1999. Characterization of MexT, the regulator of the MexE-MexF-OprN multidrug efflux system of Pseudomonas aeruginosa. J. Bacteriol. 181:6300-6305.
110. Kohler T, et al. 1997. Characterization of MexE-MexF-OprN, a positively regulated multidrug efflux system of Pseudomonas aeruginosa. Mol. Microbiol. 23:345-354.
111. Kohler T, van Delden C, Curty LK, Hamzehpour MM, Pechère JC. 2001. Overexpression of the MexEF-OprN multidrug efflux system affects cell-to-cell signaling in Pseudomonas aeruginosa. J. Bacteriol. 183: 5213-5222.
112. Kumar A, Chua KL, Schweizer HP. 2006. Method for regulated expression of single-copy efflux pump genes in a surrogate Pseudomonas aeruginosa strain: identification of the BpeEF-OprC chloramphenicol and trimethoprim efflux pump of Burkholderia pseudomallei 1026b. Antimicrob. Agents Chemother. 50:3460-3463.
113. Kumar A, Worobec EA. 2002. Fluoroquinolone resistance of Serratia marcescens: involvement of a proton gradient-dependent efflux pump. J. Antimicrob. Chemother. 50:593-596.
114. Kumar A, Worobec EA. 2005. Cloning, sequencing and characterization of the SdeAB efflux pump of Serratia marcescens. Antimicrob. Agents Chemother. 49:1495-1501.
115. Lacroix FJ, et al. 1996. Salmonella typhimurium acrB-like gene: identification and role in resistance to biliary salts and detergents and in murine infection. FEMS Microbiol. Lett. 135:161-167.
116. Lamarche MG, Déziel E. 2011. MexEF-OprN efflux pump exports the Pseudomonas quinolone signal (PQS) precursor HHQ (4-hydroxy-2-heptylquinoline). PLoS One 6:e24310. doi:10.1371/journal.pone.0024310.
117. Landman D, Bratu S, Quale J. 2009. Contribution of OmpK36 to carbapenem susceptibility in KPC-producing Klebsiella pneumoniae. J. Med. Microbiol. 58:1303-1308.
118. Lebel S, Bouttier S, Lambert T. 2004. The cme gene of Clostridium difficile confers multidrug resistance in Enterococcus faecalis. FEMS Microbiol. Lett. 238:93-100.
119. Leblanc SK, Oates CW, Raivio TL. 2011. Characterization of the induction and cellular role of the BaeSR two-component envelope stress response of Escherichia coli. J. Bacteriol. 193:3367-3375.
120. Lee EW, Huda MN, Kuroda T, Mizushima T, Tsuchiya T. 2003. EfrAB, an ABC multidrug efflux pump in Enterococcus faecalis. Antimicrob. Agents Chemother. 47:3733-3738.
121. Levy SB, Marshall B. 2004. Antibacterial resistance worldwide: causes, challenges and responses. Nat. Med. 10:S122-129.
122. Levy SB, McMurry L. 1978. Plasmid-determined tetracycline resistance involves new transport systems for tetracycline. Nature 276:90-92.
123. Li C, et al. 1999. Antimicrobial activities of amine- and guanidinefunctionalized cholic acid derivatives. Antimicrob. Agents Chemother. 43:1347-1349.
124. Li Y, et al. 2003. A new member of the tripartite multidrug efflux pumps, MexVW-OprM, in Pseudomonas aeruginosa. J. Antimicrob. Chemother. 52:572-575.
125. Li X-Z, Nikaido H. 2004. Efflux-mediated drug resistance in bacteria. Drugs 64:159-204.
126. Li XZ, Nikaido H, Poole K. 1995. Role of mexA-mexB-oprM in antibiotic efflux in Pseudomonas aeruginosa. Antimicrob. Agents Chemother. 39:1948-1953.
127. Li H, Park JT. 1999. The periplasmic murein peptide-binding protein MppA is a negative regulator of multiple antibiotic resistance in Escherichia coli. J. Bacteriol. 181:4842-4847.
128. Li XZ, Zhang L, Nikaido H. 2004. Efflux pump-mediated intrinsic drug resistance in Mycobacterium smegmatis. Antimicrob. Agents Chemother. 48:2415-2423.
129. Li X-Z, Zhang L, Poole K. 2002. SmeC, an outer membrane multidrug efflux protein of Stenotrophomonas maltophilia. Antimicrob. Agents Chemother. 46:333-343.
130. Limansky AS, Mussi MA, Viale AM. 2002. Loss of a 29-kilodalton outer membrane protein in Acinetobacter baumannii is associated with imipenem resistance. J. Clin. Microbiol. 40:4776-4778.
131. Lin J, Michel LO, Zhang Q. 2002. CmeABC functions as a multidrug efflux system in Campylobacter jejuni. Antimicrob. Agents Chemother. 46:2124-2131.
132. Lin XM, Yang JN, Peng XX, Li H. 2010. A novel negative regulation mechanism of bacterial outer membrane proteins in response to antibiotic resistance. J. Proteome Res. 9:5952-5959.
133. Liu J, Keelan P, Bennett PM, Enne VI. 2009. Characterization of a novel macrolide efflux gene, mef(B), found linked to sul3 in porcine Escherichia coli. J. Antimicrob. Chemother. 63:423-426.
134. Llanes C, et al. 2004. Clinical strains of Pseudomonas aeruginosa overproducing MexAB-OprM and MexXY efflux pumps simultaneously. Antimicrob. Agents Chemother. 48:1797-1802.
135. Llanes C, et al. 2011. Role of the MexEF-OprN efflux system in low-level resistance of Pseudomonas aeruginosa to ciprofloxacin. Antimicrob. Agents Chemother. 55:5676-5684.
136. Lomovskaya O, Kawai F, Matin A. 1996. Differential regulation of the mcb and emr operons of Escherichia coli: role of mcb in multidrug resistance. Antimicrob. Agents Chemother. 40:1050-1052.
137. Lomovskaya O, et al. 2001. Identification and characterization of inhibitors of multidrug resistance efflux pumps in Pseudomonas aeruginosa: novel agents for combination therapy. Antimicrob. Agents Chemother. 45:105-116.
138. Lou H, et al. 2011. Altered antibiotic transport in OmpC mutants isolated from a series of clinical strains of multi-drug resistant E. coli. PLoS One 6:e25825. doi:10.1371/journal.pone.0025825.
139. Lucas CE, Balthazar JT, Hagman KE, Shafer WM. 1997. The MtrR repressor binds the DNA sequence between the mtrR and mtrC genes of Neisseria gonorrhoeae. J. Bacteriol. 179:4123-4128.
140. Lynch MJ, Drusano GL, Mobley HL. 1987. Emergence of resistance to imipenem in Pseudomonas aeruginosa. Antimicrob. Agents Chemother. 31:1892-1896.
141. Ma D, Alberti M, Lynch C, Nikaido H, Hearst JE. 1996. The local repressor AcrR plays a modulating role in the regulation of acrAB genes of Escherichia coli by global stress signals. Mol. Microbiol. 19:101-112.
142. Ma D, et al. 1993. Molecular cloning and characterization of acrA and acrE genes of Escherichia coli. J. Bacteriol. 175:6299-6313.
143. Ma D, Cook DN, Hearst JE, Nikaido H. 1994. Efflux pumps and drug resistance in Gram-negative bacteria. Trends Microbiol. 2:489-493.
144. Magnet S, Courvalin P, Lambert T. 2001. Resistance-nodulation-cell division-type efflux pump involved in aminoglycoside resistance in Acinetobacter baumannii strain BM4454. Antimicrob. Agents Chemother. 45: 3375-3380.
145. Maneewannakul K, Levy SB. 1996. Identification for mar mutants among quinolone-resistant clinical isolates of Escherichia coli. Antimicrob. Agents Chemother. 40:1695-1698.
146. Maniati M, et al. 2007. A highly carbapenem-resistant Pseudomonas aeruginosa isolate with a novel blaVIM-4/blaP1b integron overexpresses two efflux pumps and lacks OprD. J. Antimicrob. Chemother. 60:132-135.
147. Mao W, Warren MS, Lee A, Mistry A, Lomovskaya O. 2001. MexXY-OprM efflux pump is required for antagonism of aminoglycosides by divalent cations in Pseudomonas aeruginosa. Antimicrob. Agents Chemother. 45:2001-2007.
148. Marger MD, Saier MH, Jr. 1993. A major superfamily of transmembrane facilitators that catalyse uniport, symport and antiport. Trends Biochem. Sci. 18:13-20.
149. Markham PN, Westhaus E, Klyachko K, Johnson ME, Neyfakh AA. 1999. Multiple novel inhibitors of the NorA multidrug transporter of Staphylococcus aureus. Antimicrob. Agents Chemother. 43:2404-2408.
150. Marrer E, et al. 2006. Involvement of the putative ATP-dependent efflux proteins PatA and PatB in fluoroquinolone resistance of a multidrugresistant mutant of Streptococcus pneumoniae. Antimicrob. Agents Chemother. 50:685-693.
151. Martinez A, Lin J. 2006. Effect of an efflux pump inhibitor on the function of the multidrug efflux pump CmeABC and antimicrobial resistance in Campylobacter. Foodborne Pathog. Dis. 3:393-402.
152. Maseda H, Saito K, Nakajima A, Nakae T. 2000. Variation of the mexT gene, a regulator of the MexEF-OprN efflux pump expression in wildtype strains of Pseudomonas aeruginosa. FEMS Microbiol. Lett. 192:107-112.
153. Maseda H, et al. 2004. Enhancement of the mexAB-oprM efflux pump expression by a quorum-sensing autoinducer and its cancellation by a regulator, MexT, of the mexEF-oprN efflux pump operon in Pseudomonas aeruginosa. Antimicrob. Agents Chemother. 48:1320-1328.
154. Masi M, Pages JM, Villard C, Pradel E. 2005. The eefABC multidrug efflux pump operon is repressed by HNS in Enterobacter aerogenes. J. Bacteriol. 187:3894-3897.
155. Masuda N, Sakagawa E, Ohya S, Gotoh N, Nishino T. 2001. Hypersusceptibility of the Pseudomonas aeruginosa nfxB mutant to betalactams due to reduced expression of the ampC beta-lactamase. Antimicrob. Agents Chemother. 45:1284-1286.
156. Matsuo T, et al. 2008. SmdAB, a heterodimeric ABC-type multidrug efflux pump, in Serratia marcescens. J. Bacteriol. 190:648-654.
157. Matsuo Y, Eda S, Gotoh N, Yoshihara E, Nakae T. 2004. MexZ-mediated regulation of mexXY multidrug efflux pump expression in Pseudomonas aeruginosa by binding on the mexZ-mexX intergenic DNA. FEMS Microbiol. Lett. 238:23-28.
158. Mazzariol A, Zuliani J, Cornaglia G, Rossolini GM, Fontana R. 2002. AcrAB efflux system: expression and contribution to fluoroquinolone resistance in Klebsiella spp. Antimicrob. Agents Chemother. 46:3984-3986.
159. McAleese F, et al. 2005. A novel MATE family efflux pump contributes to the reduced susceptibility of laboratory-derived Staphylococcus aureus mutants to tigecycline. Antimicrob. Agents Chemother. 49:1865-1871.
160. McMurry L, Petrucci RE, Jr, Levy SB. 1980. Active efflux of tetracycline encoded by four genetically different tetracycline resistance determinants in Escherichia coli. Proc. Natl. Acad. Sci. U. S. A. 77:3974-3977.
161. Medeiros AA, O'Brien TF, Rosenberg EY, Nikaido H. 1987. Loss of OmpC porin in a strain of Salmonella typhimurium causes increased resistance to cephalosporins during therapy. J. Infect. Dis. 156:751-757.
162. Mima T, Schweizer HP. 2010. The BpeAB-OprB efflux pump of Burkholderia pseudomallei 1026b does not play a role in quorum sensing, virulence factor production, or extrusion of aminoglycosides but is a broad-spectrum drug efflux system. Antimicrob. Agents Chemother. 54: 3113-3120.
163. Minato Y, Shahcheraghi F, Ogawa W, Kuroda T, Tsuchiya T. 2008. Functional gene cloning and characterization of the SsmE multidrug efflux pump from Serratia marcescens. Biol. Pharm. Bull. 31:516-519.
164. Mine T, Morita Y, Kataoka A, Mizushima T, Tsuchiya T. 1999. Expression in Escherichia coli of a new multidrug efflux pump, MexXY, from Pseudomonas aeruginosa. Antimicrob. Agents Chemother. 43:415-417.
165. Moore RA, DeShazer D, Reckseidler S, Weissman A, Woods DE. 1999. Efflux-mediated aminoglycoside and macrolide resistance in Burkholderia pseudomallei. Antimicrob. Agents Chemother. 43:465-470.
166. Morita Y, et al. 1998. NorM, a putative multidrug efflux protein, of Vibrio parahaemolyticus and its homolog in Escherichia coli. Antimicrob. Agents Chemother. 42:1778-1782.
167. Moussatova A, Kandt C, O'Mara ML, Tieleman DP. 2008. ATPbinding cassette transporters in Escherichia coli. Biochim. Biophys. Acta 1778:1757-1771.
168. Mulet X, et al. 2009. Azithromycin in Pseudomonas aeruginosa biofilms: bactericidal activity and selection of nfxB mutants. Antimicrob. Agents Chemother. 53:1552-1560.
169. Muller C, Plésiat P, Jeannot K. 2011. A two-component regulatory system interconnects resistance to polymyxins, aminoglycosides, fluoroquinolones, and-lactams in Pseudomonas aeruginosa. Antimicrob. Agents Chemother. 55:1211-1221.
170. Nagakubo S, Nishino K, Hirata T, Yamaguchi A. 2002. The putative response regulator BaeR stimulates multidrug resistance of Escherichia coli via a novel multidrug exporter system, MdtABC. J. Bacteriol. 184: 4161-4167.
171. Nagant C, et al. 2010. Interaction between tobramycin and CSA-13 on clinical isolates of Pseudomonas aeruginosa in a model of young and mature biofilms. Appl. Microbiol. Biotechnol. 88:251-263.
172. Nair BM, Cheung KJ, Jr, Griffith A, Burns JL. 2004. Salicylate induces an antibiotic efflux pump in Burkholderia cepacia complex genomovar III (B. cenocepacia). J. Clin. Invest. 113:464-473.
173. Nakae T. 1976. Identification of the outer membrane protein of E. coli that produces transmembrane channels in reconstituted vesicle membranes. Biochem. Biophys. Res. Commun. 71:877-884.
174. Nakayama K, et al. 2004. MexAB-OprM specific efflux pump inhibitors in Pseudomonas aeruginosa. Part 3: optimization of potency in the pyridopyrimidine series through the application of a pharmacophore model. Bioorg. Med. Chem. Lett. 14:475-479.
175. Nelson ML, Levy SB. 1999. Reversal of tetracycline resistance mediated by different bacterial tetracycline resistance determinants by an inhibitor of the Tet(B) antiport protein. Antimicrob. Agents Chemother. 43: 1719-1724.
176. Neyfakh AA. 1992. The multidrug efflux transporter of Bacillus subtilis is a structural and functional homolog of the Staphylococcus NorA protein. Antimicrob. Agents Chemother. 36:484-485.
177. Nikaido H, Basina M, Nguyen V, Rosenberg EY. 1998. Multidrug efflux pump AcrAB of Salmonella typhimurium excretes only those betalactam antibiotics containing lipophilic side chains. J. Bacteriol. 180: 4686-4692.
178. Nikaido H, Pagès JM. 2012. Broad-specificity efflux pumps and their role in multidrug resistance of Gram-negative bacteria. FEMS Microbiol. Rev. 36:340-363.
179. Nikaido E, Shirosaka I, Yamaguchi A, Nishino K. 2011. Regulation of the AcrAB multidrug efflux pump in Salmonella enterica serovar Typhimurium in response to indole and paraquat. Microbiology 157:648-655.
180. Nikaido E, Yamaguchi A, Nishino K. 2008. AcrAB multidrug efflux pump regulation in Salmonella enterica serovar Typhimurium by RamA in response to environmental signals. J. Biol. Chem. 283:24245-24253.
181. Nilsen IW, Bakke I, Vader A, Olsvik O, El-Gewely MR. 1996. Isolation of cmr, a novel Escherichia coli chloramphenicol resistance gene encoding a putative efflux pump. J. Bacteriol. 178:3188-3193.
182. Nishino K, Latifi T, Groisman EA. 2006. Virulence and drug resistance roles of multidrug efflux systems of Salmonella enterica serovar Typhimurium. Mol. Microbiol. 59:126-141.
183. Nishino K, Yamaguchi A. 2002. EvgA of the two-component signal transduction system modulates production of the YhiUV multidrug transporter in Escherichia coli. J. Bacteriol. 184:2319-2323.
184. Nishioka T, Ogawa W, Kuroda T, Katsu T, Tsuchiya T. 2009. Gene cloning and characterization of EfmA, a multidrug efflux pump, from Enterococcus faecium. Biol. Pharm. Bull. 32:483-488.
185. Ochs MM, Bains M, Hancock REW. 2000. Role of putative loops 2 and 3 in imipenem passage through the specific porin OprD of Pseudomonas aeruginosa. Antimicrob. Agents Chemother. 44:1983-1985.
186. Ochs MM, Lu CD, Hancock REW, Abdelal AT. 1999. Amino acidmediated induction of the basic amino acid-specific outer membrane porin OprD from Pseudomonas aeruginosa. J. Bacteriol. 181:5426-5432.
187. Ochs MM, McCusker MP, Bains M, Hancock REW. 1999. Negative regulation of the Pseudomonas aeruginosa outer membrane porin OprD selective for imipenem and basic amino acids. Antimicrob. Agents Chemother. 43:1085-1090.
188. Okazaki T, Hirai K. 1992. Cloning and nucleotide sequence of the Pseudomonas aeruginosa nfxB gene, conferring resistance to new quinolones. FEMS Microbiol. Lett. 76:197-202.
189. Olesky M, Hobbs M, Nicholas RA. 2002. Identification and analysis of amino acid mutations in porin IB that mediate intermediate-level resistance to penicillin and tetracycline in Neisseria gonorrhoeae. Antimicrob. Agents Chemother. 46:2811-2820.
190. Olesky M, Zhao S, Rosenberg RL, Nicholas RA. 2006. Porin-mediated antibiotic resistance in Neisseria gonorrhoeae: ion, solute, and antibiotic permeation through PIB proteins with penB mutations. J. Bacteriol. 188: 2300-2308.
191. Olliver A, Vall É M, Chaslus-Dancla E, Cloeckaert A. 2005. Overexpression of the multidrug efflux operon acrEF by insertional activation with IS1 or IS10 elements in Salmonella enterica serovar Typhimurium DT204 acrB mutants selected with fluoroquinolones. Antimicrob. Agents Chemother. 49:289-301.
192. Oteo J, et al. 2008. Emergence of imipenem resistance in clinical Escherichia coli during therapy. Int. J. Antimicrob. Agents 32:534-537.
193. Pagel M, et al. 2007. Phenotypic characterization of pore mutants of the Vibrio cholerae porin OmpU. J. Bacteriol. 189:8593-8600.
194. Pamp SJ, Gjermansen M, Johansen HK, Tolker-Nielsen T. 2008. Tolerance to the antimicrobial peptide colistin in Pseudomonas aeruginosa biofilms is linked to metabolically active cells, and depends on the pmr and mexAB-oprM genes. Mol. Microbiol. 68:223-240.
195. Park YJ, et al. 2009. Accumulation of plasmid-mediated fluoroquinolone resistance genes, qepA and qnrS1, in Enterobacter aerogenescoproducing RmtB and class A β-lactamase LAP-1. Ann. Clin. Lab. Sci. 39:55-59.
196. Pasca MR, et al. 2004. Rv2686c-Rv2687c-Rv2688c, an ABC fluoroquinolone efflux pump in Mycobacterium tuberculosis. Antimicrob. Agents Chemother. 48:3175-3178.
197. Paulsen IT, Skurray RA. 1993. Topology, structure and evolution of two families of proteins involved in antibiotic and antiseptic resistance in eukaryotes and prokaryotes-an analysis. Gene 124:1-11.
198. Paulsen IT, Sliwinski MK, Saier MH, Jr. 1998. Microbial genome analyses: global comparisons of transport capabilities based on phylogenies, bioenergetics and substrate specificities. J. Mol. Biol. 277:573-592.
199. Perez A, et al. 2007. Cloning, nucleotide sequencing, and analysis of the AcrAB-TolC efflux pump of Enterobacter cloacae and determination of its involvement in antibiotic resistance in a clinical isolate. Antimicrob. Agents Chemother. 51:3247-3253.
200. Poole K, et al. 1996. Overexpression of the mexC-mexD-oprJ effux operon in nfxB-type multidrug resistant strains. Mol. Microbiol. 21:713-724.
201. Poole K, Krebes K, McNally C, Neshat S. 1993. Multiple antibiotic resistance in Pseudomonas aeruginosa: evidence for involvement of an efflux operon. J. Bacteriol. 175:7363-7372.
202. Poole K, et al. 1996. Expression of the multidrug resistance operon mexA-mexB-oprM in Pseudomonas aeruginosa: mexR encodes a regulator of operon expression. Antimicrob. Agents Chemother. 40:2021-2028.
203. Pradel E, Pagès JM. 2002. The AcrAB-TolC efflux pump contributes to multidrug resistance in the nosocomial pathogen Enterobacter aerogenes. Antimicrob. Agents Chemother. 46:2640-2643.
204. Pratt LA, Hsing W, Gibson KE, Silhavy TJ. 1996. From acids to osmZ: multiple factors influence synthesis of the OmpF and OmpC porins in Escherichia coli. Mol. Microbiol. 20:911-917.
205. Rahman MM, et al. 2007. Molecular cloning and characterization of all RND-type efflux transporters in Vibrio cholerae non-O1. Microbiol. Immunol. 51:1061-1070.
206. Rahman SS, Simovic I, Gibbons S, Zloh M. 2011. In silico screening for antibiotic escort molecules to overcome efflux. J. Mol. Model. 17:2863-2872.
207. Rahmati S, Yang S, Davidson AL, Zechiedrich EL. 2002. Control of the AcrAB multidrug efflux pump by quorum-sensing regulator SdiA. Mol. Microbiol. 43:677-685.
208. Rella M, Haas D. 1982. Resistance of Pseudomonas aeruginosa PAO to nalidixic acid and low levels of beta-lactam antibiotics: mapping of chromosomal genes. Antimicrob. Agents Chemother. 22:242-249.
209. Renau TE, et al. 1999. Inhibitors of efflux pumps in Pseudomonas aeruginosa potentiate the activity of the fluoroquinolone antibacterial levofloxacin. J. Med. Chem. 42:4928-4931.
210. Riordan JT, et al. 2011. Alterations in the transcriptome and antibiotic susceptibility of Staphylococcus aureus grown in the presence of diclofenac. Ann. Clin. Microbiol. Antimicrob. 10:30. doi:10.1186/1476-0711-10-30.
211. Robertson GT, Doyle TB, Lynch AS. 2005. Use of an efflux-deficient Streptococcus pneumoniae strain panel to identify ABC-class multidrug transporters involved in intrinsic resistance to antimicrobial agents. Antimicrob. Agents Chemother. 49:4781-4783.
212. Rosenberg EY, Ma D, Nikaido H. 2000. AcrD of Escherichia coli is an aminoglycoside efflux pump. J. Bacteriol. 182:1754-1756.
213. Ross JI, et al. 1990. Inducible erythromycin resistance in staphylococci is encoded by a member of the ATP-binding transport super-gene family. Mol. Microbiol. 4:1207-1214.
214. Rouch DA, Cram DS, DiBerardino D, Littlejohn TG, Skurray RA. 1990. Efflux-mediated antiseptic resistance gene qacA from Staphylococcus aureus: common ancestry with tetracycline- and sugar-transport proteins. Mol. Microbiol. 4:2051-2062.
215. Rouquette-Loughlin CE, Balthazar JT, Shafer WM. 2005. Characterization of the MacA-MacB efflux system in Neisseria gonorrhoeae. J. Antimicrob. Chemother. 56:856-860.
216. Rouquette-Loughlin C, Dunham SA, Kuhn M, Balthazar JT, Shafer WM. 2003. The NorM efflux pump of Neisseria gonorrhoeae and Neisseria meningitidis recognizes antimicrobial cationic compounds. J. Bacteriol. 185:1101-1106.
217. Ruzin A, Visalli MA, Keeney D, Bradford PA. 2005. Influence of transcriptional activator RamA on expression of multidrug efflux pump AcrAB and tigecycline susceptibility in Klebsiella pneumoniae. Antimicrob. Agents Chemother. 49:1017-1022.
218. Sanbongi Y, et al. 2009. Classification of OprD sequence and correlation with antimicrobial activity of carbapenem agents in Pseudomonas aeruginosa clinical isolates collected in Japan. Microbiol. Immunol. 53:361-367.
219. Sánchez P, Alonso A, Martinez JL. 2002. Cloning and characterization of SmeT, a repressor of the Stenotrophomonas maltophilia multidrug efflux pump SmeDEF. Antimicrob. Agents Chemother. 46:3386-3393.
220. Sánchez P, et al. 2002. Fitness of in vitro selected Pseudomonas aeruginosa nalB and nfxB multidrug resistant mutants. J. Antimicrob. Chemother. 50:657-664.
221. Sanchez L, Pan W, Vinas M, Nikaido H. 1997. The acrAB homolog of Haemophilus influenzae codes for a functional multidrug efflux pump. J. Bacteriol. 179:6855-6857.
222. Savage PB, Li C. 2000. Cholic acid derivatives: novel antimicrobials. Expert. Opin. Invest. Drugs 9:263-272.
223. Sawada I, Maseda H, Nakae T, Uchiyama H, Nomura N. 2004. A quorum-sensing autoinducer enhances the mexAB-oprM efflux-pump expression without the MexR-mediated regulation in Pseudomonas aeruginosa. Microbiol. Immunol. 48:435-439.
224. Scott MG, Yan H, Hancock REW. 1999. Biological properties of structurally related α-helical cationic antimicrobial peptides. Infect. Immun. 67:2005-2009.
225. Shahcheraghi F, et al. 2007. Molecular cloning and characterization of a multidrug efflux pump, SmfY, from Serratia marcescens. Biol. Pharm. Bull. 30:798-800.
226. Shen Z, Pu XY, Zhang Q. 2011. Salicylate functions as an efflux pump inducer and promotes the emergence of fluoroquinolone-resistant Campylobacter jejuni mutants. Appl. Environ. Microbiol. 77:7128-7133.
227. Siddiqi N, et al. 2004. Mycobacterium tuberculosis isolate with a distinct genomic identity overexpresses a Tap-like efflux pump. Infection 32: 109-111.
228. Singh AK, Haldar R, Mandal D, Kundu M. 2006. Analysis of the topology of Vibrio cholerae NorM and identification of amino acid residues involved in norfloxacin resistance. Antimicrob. Agents Chemother. 50:3717-3723.
229. Singh KV, Malathum K, Murray BE. 2001. Disruption of an Enterococcus faecium species-specific gene, a homologue of acquired macrolide resistance genes of staphylococci, is associated with an increase in macrolide susceptibility. Antimicrob. Agents Chemother. 45:263-266.
230. Sobel ML, Hocquet D, Cao L, Plesiat P, Poole K. 2005. Mutations in PA3574 (nalD) lead to increased MexAB-OprM expression and multidrug resistance in laboratory and clinical isolates of Pseudomonas aeruginosa. Antimicrob. Agents Chemother. 49:1782-1786.
231. Song W, et al. 2009. In vivo selection of carbapenem-resistant Klebsiella pneumoniae by OmpK36 loss during meropenem treatment. Diagn. Microbiol. Infect. Dis. 65:447-449.
232. Srikumar R, Paul CJ, Poole K. 2000. Influence of mutations in the mexR repressor gene on expression of the MexA-MexB-OprM multidrug efflux system of Pseudomonas aeruginosa. J. Bacteriol. 182:1410-1414.
233. Srinivasan VB, Rajamohan G, Gebreyes WA. 2009. Role of AbeS, a novel efflux pump of the SMR family of transporters, in resistance to antimicrobial agents in Acinetobacter baumannii. Antimicrob. Agents Chemother. 53:5312-5316.
234. Stickland HG, Davenport PW, Lilley KS, Griffin JL, Welch M. 2010. Mutation of nfxB causes global changes in the physiology and metabolism of Pseudomonas aeruginosa. J. Proteome Res. 9:2957-2967.
235. Stürenburg E, Sobottka I, Mack D, Laufs R. 2002. Cloning and sequencing of Enterobacter aerogenes OmpC-type osmoporin linked to carbapenem resistance. Int. J. Med. Microbiol. 291:649-654.
236. Su XZ, Chen J, Mizushima T, Kuroda T, Tsuchiya T. 2005. AbeM, an H+ -coupled Acinetobacter baumannii multidrug efflux pump belonging to the MATE family of transporters. Antimicrob. Agents Chemother. 49:4362-4364.
237. Suh B, et al. 2010. Outbreak of meropenem-resistant Serratia marcescens comediated by chromosomal AmpC beta-lactamase overproduction and outer membrane protein loss. Antimicrob. Agents Chemother. 54:5057-5061.
238. Tavío MM, et al. 2004. Enhanced active efflux, repression of porin synthesis and development of Mar phenotype by diazepam in two enterobacteria strains. J. Med. Microbiol. 53:1119-1122.
239. Tennent JM, et al. 1989. Physical and biochemical characterization of the qacA gene encoding antiseptic and disinfectant resistance in Staphylococcus aureus. J. Gen. Microbiol. 135:1-10.
240. Thanassi DG, Cheng LW, Nikaido H. 1997. Active efflux of bile salts by Escherichia coli. J. Bacteriol. 179:2512-2518.
241. Thiolas A, Bornet C, Davin-Régli A, Pagès JM, Bollet C. 2004. Resistance to imipenem, cefepime, and cefpirome associated with mutation in Omp36 osmoporin of Enterobacter aerogenes. Biochem. Biophys. Res. Commun. 317:851-856.
242. Tomás M, et al. 2010. Efflux pumps, OprD porin, AmpC beta-lactamase, and multiresistance in Pseudomonas aeruginosa isolates from cystic fibrosis patients. Antimicrob. Agents Chemother. 54:2219-2224.
243. Toro CS, Lobos SR, Calderón I, Rodríguez M, Mora GC. 1990. Clinical isolate of a porinless Salmonella typhi resistant to high levels of chloramphenicol. Antimicrob. Agents Chemother. 34:1715-1719.
244. Truong-Bolduc QC, et al. 2011. Implication of the NorB efflux pump in the adaptation of Staphylococcus aureus to growth at acid pH and in resistance to moxifloxacin. Antimicrob. Agents Chemother. 55:3214-3219.
245. Truong-Bolduc QC, Dunman PM, Strahilevitz J, Projan SJ, Hooper DC. 2005. MgrA is a multiple regulator of two new efflux pumps in Staphylococcus aureus. J. Bacteriol. 187:2395-2405.
246. Truong-Bolduc QC, Hooper DC. 2007. The transcriptional regulators NorG and MgrA modulate resistance to both quinolones and β-lactams in Staphylococcus aureus. J. Bacteriol. 189:2996-3005.
247. Truong-Bolduc QC, Strahilevitz J, Hooper DC. 2006. NorC, a new efflux pump regulated by MgrA of Staphylococcus aureus. Antimicrob. Agents Chemother. 50:1104-1107.
248. Tsubery H, Ofek I, Cohen S, Fridkin M. 2000. Structure-function studies of polymyxin B nonapeptide: implications to sensitization of gram-negative bacteria. J. Med. Chem. 43:3085-3092.
249. Ubukata K, Itoh-Yamashita N, Konno M. 1989. Cloning and expression of the norA gene for fluoroquinolone resistance in Staphylococcus aureus. Antimicrob. Agents Chemother. 33:1535-1539.
250. Vaara M. 1992. Agents that increase the permeability of the outer membrane. Microbiol. Rev. 56:395-411.
251. Venkatraman J, Nagana Gowda GA, Balaram P. 2002. Structural analysis of synthetic peptide fragments from EmrE, a multidrug resistance protein, in a membrane-mimetic environment. Biochemistry 41:6631-6639.
252. Vettoretti L, et al. 2009. Efflux unbalance in Pseudomonas aeruginosa isolates from cystic fibrosis patients. Antimicrob. Agents Chemother. 53:1987-1997.
253. Vila J, Martí S, Sánchez-Céspedes J. 2007. Porins, efflux pumps and multidrug resistance in Acinetobacter baumannii. J. Antimicrob. Chemother. 59:1210-1215.
254. Visalli MA, Murphy E, Projan SJ, Bradford PA. 2003. AcrAB multidrug efflux pump is associated with reduced levels of susceptibility to tigecycline (GAR-936) in Proteus mirabilis. Antimicrob. Agents Chemother. 47:665-669.
255. Viveiros M, et al. 2007. Antibiotic stress, genetic response and altered permeability of E. coli. PLoS One 2:e365. doi:10.1371/journal.pone.0000365.
256. Vogne C, Aires JR, Bailly C, Hocquet D, Plésiat P. 2004. Role of the multidrug efflux system MexXY in the emergence of moderate resistance to aminoglycosides among Pseudomonas aeruginosa isolates from patients with cystic fibrosis. Antimicrob. Agents Chemother. 48:1676-1680.
257. Wang H, et al. 2010. oprM as a new target for reversion of multidrug resistance in Pseudomonas aeruginosa by antisense phosphorothioate oligodeoxynucleotides. FEMS Immunol. Med. Microbiol. 60:275-282.
258. Weindorf H, Schmidt H, Martin HH. 1998. Contribution of overproduced chromosomal beta-lactamase and defective outer membrane porins to resistance to extended-spectrum beta-lactam antibiotics in Serratia marcescens. J. Antimicrob. Chemother. 41:189-195.
259. Westbrock-Wadman S, et al. 1999. Characterization of a Pseudomonas aeruginosa efflux pump contributing to aminoglycoside impermeability. Antimicrob. Agents Chemother. 43:2975-2983.
260. Westfall LW, et al. 2006. mvaT mutation modifies the expression of the Pseudomonas aeruginosa multidrug efflux operon mexEF-oprN. FEMS Microbiol. Lett. 255:247-254.
261. Wolter DJ, Hanson ND, Lister PD. 2004. Insertional inactivation of oprD in clinical isolates of Pseudomonas aeruginosa leading to carbapenem resistance. FEMS Microbiol. Lett. 236:137-143.
262. Woolridge DP, et al. 1997. Efflux of the natural polyaminespermidine facilitated by the Bacillus subtilis multidrug transporter Blt. J. Biol. Chem. 272:8864-8866.
263. Yamada Y, Hideka K, Shiota S, Kuroda T, Tsuchiya T. 2006. Gene cloning and characterization of SdrM, a chromosomally encoded multidrug efflux pump, from Staphylococcus aureus. Biol. Pharm. Bull. 29: 554-556.
264. Yamamoto M, et al. 2009. Role of MexZ and PA5471 in transcriptional regulation of mexXY in Pseudomonas aeruginosa. Microbiology 155: 3312-3321.
265. Yamane K, et al. 2007. New plasmid-mediated fluoroquinolone efflux pump, QepA, found in an Escherichia coli clinical isolate. Antimicrob. Agents Chemother. 51:3354-3360.
266. Yang S, Clayton SR, Zechiedrich EL. 2003. Relative contributions of the AcrAB, MdfA and NorE efflux pumps to quinolone resistance in Escherichia coli. J. Antimicrob. Chemother. 51:545-556.
267. Yassein MA, Ewis HE, Lu C-D, Abdelal AT. 2002. Molecular cloning and characterization of the Salmonella enterica serovar Paratyphi B rma gene, which confers multiple drug resistance in Escherichia coli. Antimicrob. Agents Chemother. 44:10-13.
268. Zähner D, et al. 2010. Human antimicrobial peptide LL-37 induces MefE/Mel-mediated macrolide resistance in Streptococcus pneumoniae. Antimicrob. Agents Chemother. 54:3516-3519.
269. Zhang DF, Jiang B, Xiang ZM, Wang SY. 2008. Functional characterisation of altered outer membrane proteins for tetracycline resistance in Escherichia coli. Int. J. Antimicrob. Agents 32:315-319.
270. Zhang L, Li X-Z, Poole K. 2001. SmeDEF multidrug efflux pump contributes to intrinsic multidrug resistance in Stenotrophomonas maltophilia. Antimicrob. Agents Chemother. 45:3497-3503.
271. Zhang L, Mah TF. 2008. Involvement of a novel efflux system in biofilmspecific resistance to antibiotics. J. Bacteriol. 190:4447-4452.
272. Ziha-Zarifi I, Llanes C, Köhler T, Pechere JC, Plesiat P. 1999. In vivo emergence of multidrug-resistant mutants of Pseudomonas aeruginosa overexpressing the active efflux system MexA-MexB-OprM. Antimicrob. Agents Chemother. 43:287-291.